Among the efficacy evaluable patients, 42% achieved complete remission within 3 months. The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Syncona Shs GBP (GB:SYNC) has released an update. Syncona’s portfolio company, Autolus Therapeutics, has received FDA ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Autolus Therapuetics plc has been granted FDA approval for Aucatzyl (obecabtagene autoleucel) for the treatment of acute lymphoblastic leukemia in adults, becoming the first marketed CAR T therapy ...

Introduction: Chronic lymphocytic leukemia (CLL) is prevalent among adults in Western ... Despite growing recognition, understanding of acute HF's epidemiology, outcomes, and risk factors in CLL ...

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

coli," the agency wrote. E. coli symptoms usually start about two to seven days after exposure, CBS News chief medical correspondent Dr. Jon LaPook said on the "CBS Evening News" Tuesday.

Alessandra Ferrajoli, MD, discusses the importance of supportive care in the management of patients with chronic lymphocytic ...

If they cause symptoms, you may need to have your gallbladder removed. The gallbladder is a small organ in the upper right abdomen, right below your liver. It’s a pouch that stores bile ...

Johns Hopkins is home to one of the largest leukemia programs worldwide. Groundbreaking treatments in all types of leukemias and blood disorders are just the beginning of unparalleled care and ...